Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | 0.00% | -25.00% | -82.35% |
Apr. 12 | Neurizer's Comprehensive Loss Shrinks in Half-Year 2023 | MT |
Apr. 11 | NeuRizer Ltd. Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 79.24 | 142.5 | 43.86 | 122 | 171.8 | 73.51 |
Enterprise Value (EV) 1 | 73.6 | 143.4 | 37.87 | 99.43 | 171.7 | 74.74 |
P/E ratio | -8.75 x | -11.8 x | -5.31 x | -7.28 x | -7.26 x | -3.73 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -12.6 x | -19.3 x | -5.43 x | -7.37 x | -14 x | -5.52 x |
EV / FCF | -3.4 x | -5.73 x | 402 x | -20.6 x | 28.3 x | 18.2 x |
FCF Yield | -29.4% | -17.5% | 0.25% | -4.85% | 3.53% | 5.5% |
Price to Book | 3.12 x | 4.79 x | 1.28 x | 2.38 x | 3.04 x | 1.01 x |
Nbr of stocks (in thousands) | 452,781 | 548,143 | 654,662 | 813,483 | 954,415 | 1,245,921 |
Reference price 2 | 0.1750 | 0.2600 | 0.0670 | 0.1500 | 0.1800 | 0.0590 |
Announcement Date | 8/22/18 | 8/28/19 | 8/28/20 | 9/28/21 | 9/30/22 | 10/1/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Juni | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -5.849 | -7.441 | -6.972 | -13.5 | -12.29 | -13.54 |
EBIT 1 | -5.889 | -7.5 | -7.028 | -13.55 | -12.45 | -13.58 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -6.019 | -9.535 | -7.155 | -13.57 | -20.4 | -16.26 |
Net income 1 | -6.019 | -9.535 | -7.155 | -13.57 | -20.4 | -16.26 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.0200 | -0.0220 | -0.0126 | -0.0206 | -0.0248 | -0.0158 |
Free Cash Flow 1 | -21.65 | -25.04 | 0.0942 | -4.825 | 6.067 | 4.112 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/22/18 | 8/28/19 | 8/28/20 | 9/28/21 | 9/30/22 | 10/1/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 0.93 | - | - | - | 1.23 |
Net Cash position 1 | 5.64 | - | 5.99 | 22.6 | 0.12 | - |
Leverage (Debt/EBITDA) | - | -0.1252 x | - | - | - | -0.0909 x |
Free Cash Flow 1 | -21.7 | -25 | 0.09 | -4.82 | 6.07 | 4.11 |
ROE (net income / shareholders' equity) | -30.7% | -34.6% | -22.4% | -31.8% | -37.8% | -25.2% |
ROA (Net income/ Total Assets) | -13.9% | -13.3% | -12.4% | -18.6% | -10.6% | -7.71% |
Assets 1 | 43.2 | 71.73 | 57.79 | 73.05 | 192.4 | 211 |
Book Value Per Share 2 | 0.0600 | 0.0500 | 0.0500 | 0.0600 | 0.0600 | 0.0600 |
Cash Flow per Share 2 | 0.0200 | 0.0100 | 0.0100 | 0.0300 | 0 | 0 |
Capex 1 | 15.5 | 20.3 | 2.76 | 3.66 | 6.24 | 25.3 |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 8/22/18 | 8/28/19 | 8/28/20 | 9/28/21 | 9/30/22 | 10/1/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.35% | 3.28M | |
+19.30% | 39.84B | |
-.--% | 11.22B | |
-1.90% | 7.72B | |
+2.60% | 6.54B | |
-4.02% | 6.06B | |
-4.27% | 5.7B | |
-12.91% | 5.52B | |
+29.81% | 5.13B | |
-16.83% | 4.44B |
- Stock Market
- Equities
- NRZ Stock
- Financials NeuRizer Ltd.